Filing Flows › Inogen (INGN) › R&D spending
Inogen (INGN) R&D spending by quarter
Inogen's R&D spending was $5.9M in Q2 2026 (second quarter 2026), +15% from Q1 2026. Over the last 7 quarters it ranged from $4.0M (Q1 2025) to $5.9M (Q4 2024).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $5.9M | +15% | +13% |
| Q1 2026 | $5.1M | -4% | +26% |
| Q4 2025 | $5.3M | +10% | -10% |
| Q3 2025 | $4.8M | -7% | — |
| Q2 2025 | $5.2M | +29% | — |
| Q1 2025 | $4.0M | -32% | — |
| Q4 2024 | $5.9M | — | — |
Q2 2026 at a glance
Inogen, Q2 2026: revenue $95.1M (+3% year over year), operating margin -5.4%, net loss $3.9M, operating cash flow $2.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Inogen's R&D spending?
Inogen's R&D spending was $5.9M in Q2 2026 (second quarter 2026), +15% from Q1 2026.
How has Inogen's R&D spending changed?
Over the last 7 quarters it ranged from $4.0M (Q1 2025) to $5.9M (Q4 2024).